Tagungen und Workshops zum Thema Pharmakologie und Arzneimittelentwicklung

Wählen Sie ein Land aus
37th ACS National Medicinal Chemistry Symposium
26. Jun 2022 - 29. Jun 2022 • New York, Vereinigte Staaten
American Chemical Society (ACS) Division of Medicinal Chemistry
The Division of Medicinal Chemistry of the ACS organizes its National Medicinal Chemistry Symposium in even-numbered years since 1948.
Gordon Research Conference — Drug Resistance
26. Jun 2022 - 01. Jul 2022 • Bryant University, Smithfield, Vereinigte Staaten
Gordon Research Conference — Personalized Medicine
26. Jun 2022 - 01. Jul 2022 • Ventura, Vereinigte Staaten
22nd Tetrahedron Symposium — Catalysis for a Sustainable World
28. Jun 2022 - 01. Jul 2022 • Lissabon, Portugal
The annual Tetrahedron Symposium is the premier conference in organic, bio-organic and medicinal chemistry. Join us in Lisbon for a topical programme which will bring together an expert line-up of invited speakers to communicate and share their latest results.
Einsendeschluss für Abstracts:
18. Feb 2022
Gordon Research Seminar — Drug Metabolism
09. Jul 2022 - 10. Jul 2022 • Holderness School, Holderness, Vereinigte Staaten
Gordon Research Conference — Drug Metabolism
10. Jul 2022 - 15. Jul 2022 • Holderness School, Holderness, Vereinigte Staaten
Gordon Research Seminar — Drug Carriers in Medicine and Biology
30. Jul 2022 - 31. Jul 2022 • Mount Snow, West Dover, Vereinigte Staaten
Gordon Research Conference — Drug Carriers in Medicine and Biology
31. Jul 2022 - 05. Aug 2022 • Mount Snow, West Dover, Vereinigte Staaten
20th Annual Discovery on Target
17. Aug 2022 - 20. Aug 2022 • Boston, Vereinigte Staaten
Cambridge Healthtech Institute
Discovery on Target (DOT) highlights advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents ranging from biologics to small molecules.

We aim to meet your research needs. Visit numerous concurrent sessions for informative presentations, lively dialogue, and meaningful connections with peers. Customize your experience further through focused short courses, interactive discussions, and networking options that help you engage with experts and solutions providers.

Our 20th Annual event brings back popular topics like PROTACs and RNA plus new programming on immunomodulation, antivirals, neurodegeneration targets, KRAS, and AI.

Tel.: [7812476254];     Email: ebell@healthtech.com
PROTACs and Molecular Glues – Part 1, Target Identification and Validation – Part 1, Targeting RNA, Small Molecule Immuno-Oncology Targets, GPCR-Based Drug Discovery, Antibodies Against Membrane Protein Targets – Part 1, Targeting KRAS and Other Small G Proteins, Artificial Intelligence in Drug Discovery – Part 1, PROTACs and Molecular Glues – Part 2, Target Identification and Validation – Part 2, New Antivirals, NASH and Fibrosis, Neurodegeneration Targets, Antibodies Against Membrane Protein Targets – Part 2, Drug Lead Generation Strategies, Artificial Intelligence in Drug Discovery – Part 2,
Verwandte Fachgebiete:
Bio-IT World Conference and Expo
18. Aug 2022 - 19. Aug 2022 • Berlin, Vereinigte Staaten
Cambridge Healthtech Institute
For over 20 years, the Bio-IT World Conference & Expo has been the world’s premier event showcasing the technologies and analytic approaches that solve problems, accelerate science, and drive the future of precision medicine. Bio-IT World has united a community of leading life sciences, pharmaceutical, clinical, healthcare, informatics, and technology experts in the fields of biomedical research, drug discovery & development, and healthcare from around the world. Since 2002, the Bio-IT World Conference & Expo has taken place annually in Boston and on 18-19 October, 2022, the event will host conversations that connect the people, ideas, and opportunities across Europe. Join your colleagues for updates from inspiring keynotes, more than 60 presentations across five tracks, and 2 days of interactive discussion and networking.
Tel.: [7812476254];     Email: ebell@healthtech.com
GP2A 30th Annual Conference
24. Aug 2022 - 26. Aug 2022 • Dublin , Irland
Group for the Promotion of Pharmaceutical chemistry in Academia (GP2A)
The Group for the Promotion of Pharmaceutical chemistry in Academia (GP2A) is a member-led network of academic medicinal chemists working in universities and research institutes in Europe.Founded in 1992, as the Groupement des Pharmacochimistes de l’Arc Atlantique (GP2A) by medicinal chemists working within Schools of Pharmacy near the western coast of Europe (the “Atlantic Arc”), it has rapidly expanded and currently includes academic members from France, Spain, Germany, Portugal, Ireland and the United Kingdom.
Einsendeschluss für Abstracts:
03. Jun 2022
EFMC-ISMC 2022 — XXVII EFMC International Symposium on Medicinal Chemistry
04. Sep 2022 - 08. Sep 2022 • Nizza, Frankreich
The XXVll EFMC International Symposium on Medicinal Chemistry is organised by the Société de Chimie Thérapeutique (SCT), on behalf of the European Federation for Medicinal Chemistry and Chemical Biology (EFMC).
The EFMC is the main organisation for the European Medicinal Chemistry and Chemical Biology community, with 26 member societies and about 7.500 members. Its biennial EFMC-ISMC is a key symposium in the field of medicinal chemistry and drug discovery and it traditionally attracts around 1.000 participants both from industry and academia. The most recent EFMC-ISMC meeting took place in tSlovenia (Ljubljana, 2018), while the edition initially planned for Basel, Switzerland in 2020 has been run as a Virtual Event in 2021.

The 2022 programme will cover advances in drug discovery in major therapeutic areas, including bacterial and viral infections, with a particular attention to current and emerging viral pandemics, but also neurodegenerative and cardiovascular diseases, rare diseases and cancer. EFMC-ISMC 2022 will also feature most recent advances in new technologies such as the exploitation of RNA as drug target, artificial intelligence in drug discovery, natural products-based drug discovery, DNA encoded libraries applications and the development of covalent drugs, PROTACs and molecular glues. Innovative approaches in medicinal chemistry will be included such as the development of immunomodulating compounds or the application of affinity selection – mass spectrometry for drug discovery. In a series of dedicated sessions, the interface between chemical biology and drug discovery will be highlighted, including topics such as in vivo chemistry for target discovery and validation, molecular imaging, and photochemical approaches. Finally, particular emphasis will again be put on first time disclosures and recent highlights in medicinal chemistry.

Einsendeschluss für Abstracts:
24. Mär 2022
IC2AR 2022 — 5th International Caparica Conference in Antibiotic Resistance 2022
05. Sep 2022 - 08. Sep 2022 • Caparica, Portugal
In the last years, there is a great concern about the problem of bacterial resistance to antibiotics used in human medicine as well as in veterinary. The use of antibiotics constitutes an important factor for the selection of resistance, not only among pathogenic bacteria but also among the commensal ones. Antimicrobial resistance is a major problem in public health due to the possibility of therapeutic failure. The appearance of multiresistant bacteria is probably accompanied by co-contamination of the environment, leading to a major clinical and public health concern within the lifetime of most people living today. The extensive use has heightened concerns about the expression of antimicrobial resistance, which impacts human and animal safety, food safety and environmental exposure. Antibiotic resistance is an emergent problem, and for this reason, the WHO appealed for an urgent and concerted action by governments, health professionals, industry, civil society and patients to slow down the spread of drug resistance, limit its impact today and preserve medical advances for future generations. In the latest years, much investigation was developed to understand the emergence of the resistance genes and their spread but this fact does not let us control totally this problem. In this conference, an attempt has been made to present the latest research on possibilities to manage this question.
Einsendeschluss für Abstracts:
15. Mär 2022
Verwandte Fachgebiete:
7th Edition of Global Conference on Pharmaceutics and Novel Drug Delivery Systems
08. Sep 2022 - 10. Sep 2022 • Paris, Frankreich
Magnus Groups
We provide a one-of-a-kind and precisely managed agenda that blends the most relevant marketing and sales information. This summit is the eyes and ears of Pharma industry, brimming with inspirational content, the latest marketing and sales trends, and actionable ways to utilize digital opportunities so you can have an overview of the recent trends in the field of Drug delivery and pharmaceutics. Many academicians, researchers, scientists, pharmacists and industry representatives working in these promising fields will attend this conference.
Email: pharma@magnusconference.com
Formulation Technologies Advanced Drug Delivery Systems Pharmacology Preformulation Studies Pharmacovigilance and Drug Safety Biotherapy and Radiopharmaceuticals
SANAUS — Spatial Biology US: In-person
15. Sep 2022 - 16. Sep 2022 • Boston, Vereinigte Staaten
Oxford Global
Join 500+ leaders, experts and researchers at the Spatial Biology US: In-Person, connecting global academic & research organisations as well as pharma representatives for high-level discussions on the latest innovations in spatial research & technologies.
Email: d.dalby@oxfordglobal.co.uk
Spatial, Biology, academic, research, pharma, technologies, spatial expert, spatial research, spatial technologies, workshops, presentations, spatial biology, spatial genomics, multi-omics, spatial transcriptomics, spatial metabolomics, single-cell, single-cell transcriptome imaging, spatial data analysis,
Verwandte Fachgebiete:
Aseptic Prcoessing — 2nd Annual Aseptic Processing Conference
19. Sep 2022 - 20. Sep 2022 • London, Großbritannien
SAE Media Group
Join us to discuss and address the Guidance and Regulation including the EU GMP Annex 1, environmental control delving into the contamination control strategy, Pharma moving forward 4.0 covering data integrity and data consistency, robotics in aseptic processing and exploring the continued aseptic processing development in Annex 1 and environmental monitoring
Tel.: [02078276162];     Email: ssapal@smi-online.co.uk
Aseptic Processing, Pharmaceutical Aseptic Processing, Environmental Monitoring, EM, ATMP, Advanced Therapy Media Fill, GMP, Contaminant Particles, Medicinal Product, Pharmaceutical Microbiology, Fill Finish, Media Fill, Isolators, Microbiology, Aseptic Technique, Sterility, Bioburden, Mycoplasma, Quality Control, Rapid Microbial Methods, Data Integrity, Risk Assessments, Endotoxins, Microbiome
Oligonucleotide Therapeutics and Delivery Conference 2022
21. Sep 2022 - 22. Sep 2022 • London, Großbritannien
SMi Group
Oligonucleotide Therapeutics and Delivery Conference 2022

Date: 21st – 22nd September 2022

Location: London, UK

Website: www.oligonucleotide.co.uk/evvnt

Advancements in extra-hepatic delivery of oligonucleotides

The Oligonucleotide Therapeutics and Delivery conference reveals the latest in oligonucleotide discovery and delivery, with presentations on targeted delivery mechanisms, oligonucleotide chemistries and important clinical advances. Global experts from big pharma and leading biotechs will explore the emerging therapeutic applications of oligonucleotides with case studies surrounding the discovery and development of oligonucleotide therapeutics as well as CMC and regulatory standpoints. The two-day conference will bring you high-quality insights and industry connections on the latest clinical trial candidates and a platform for exchanging ideas for tackling the biggest challenge: DELIVERY.

Established on the success of our RNA Therapeutics series, we look forward to welcoming you at Oligonucleotide Therapeutics and Delivery to join the conversation around maximizing the potential of oligo-based treatments.

Benefits of attending:

•Listen to case studies presenting on pre-clinical and clinical research in areas such as oncology and what can be learned for future clinical trials

•Deepen your understanding of oligonucleotide therapeutic delivery and explore the latest innovations in extrahepatic oligonucleotide delivery and target specificity

• Understand the regulatory and CMC environment surrounding oligonucleotide therapeutic development

•Explore developments in oligonucleotide chemistries and examine developments in novel applications of antisense oligonucleotides and siRNA

•Engage in the latest innovations in oligonucleotide therapeutics such as utilising AI machine learning to drive the discovery of novel therapeutics

Plus, two interactive half day pre-conference workshops on 20th September 2022:

•Oligonucleotide Therapies- Overcoming The Challenges Of Delivery led by Nick Lench, Executive Director, NATA, Martin Kerr, Head of Business Development & Partnerships, Nucleic Acid Therapy Accelerator, Ritwick Sawakar, MRC Investigator, MRC Toxicology Unit, University Of Cambridge

•Managing CMC Activities For The Development Of Oligonucleotide Therapeutics led by Mia Kiistala, CEO/Owner/Principal Consultant, Aurora CMC Consulting


•Ekkehard Leberer, Senior Life Sciences Consultant, Elbicon

•Jimmy Weterings, Principal Scientist, AstraZeneca


•Shalini Anderson, Vice President Oligonucleotide Discovery,AstraZeneca

•Heinrich Haas, Vice President RNA Formulation & Drug Delivery, BioNTech

•Tamar Grossman, Global Head of RNA and Targeted Therapeutics, Janssen pharmaceuticals

•Sarah Tabrizi,Director of UCL Huntington’s disease centre, UCL Institute of Neurology

•Macarena Hernandez-Jimenez, Chief Scientific Officer, AptaTargets

•David Evans, Chief Scientific Officer, Sirnaomics

•Eric Lim, Director, Platform, Discover Research, Stoke Therapeutics, Inc.

•Chris Chorley, Associate Director, Global Regulatory CMC, Biogen

•Oliver Ernst, Managing Director, Chief Operating Officer, Neuway Pharma GmbH

Nick Lench, Executive Director, Nucleic Acid Therapy Accelerator

Bart Anderson, Senior Director of R&D, Exicure

Who should attend:

Executives, Directors, VPs, Heads, Principals, Managers of:

-RNA Biology/Discovery

-Novel Therapeutic Modalities

-Innovation Technologies

-C-level Scientific Executives

-Formulation and Drug Delivery

-Clinical Research and Development

-Cell Biology



Additional Contact Info:

T: +44 (0)2 £200 0 7827 6154

E: ngaloria@smi-online.co.uk

LinkedIn: SMi Pharma

Twitter: @SMiPharma | #SMiOligonucleotides

Tel.: [+44 (0) 20 7827 6154];     Email: ngaloria@smi-online.co.uk
Small interfering RNA, siRNA, Antisense therapy, DNA, RNA, nucleic acid, mRNA, Micro RNA, RNA-induced silencing complex, RISC, Aptamers, oligonucleotide, peptide molecules, Immunogenicity, Drug pipeline, short interfering RNA, silencing RNA, RNA interference, RNAi, mRNA degradation
Verwandte Fachgebiete:
Equipment Validation, Tracking, Calibration and Preventive Maintenance
23. Sep 2022 • online, Vereinigte Staaten

FDA and EU regulations require that firms have a program for the calibration and maintenance of test and measurement equipment.

The program must include: intervals, scheduling, specific procedures, limits of accuracy/precision, and remedial action in the event that the equipment does not meet established requirements.

Compliance4all;     Tel.: [8004479407];     Email: support@compliance4All.com
Verwandte Fachgebiete:
Onshore Oil & Gas Water Management Permian Basin
27. Sep 2022 - 28. Sep 2022 • Houston, Vereinigte Staaten
American Business Conferences
This congress covers topics such as water re-use, analysing and extracting chemicals and minerals in water, subsurface disposal, use of water in fracking, reducing oil in water, and many more important topics.
Event Secretariat;     Email: info@lbcg.com
water, permian basin, re-use, oil, gas
Verwandte Fachgebiete:
2nd HPAPI Handling & Manufacturing Summit
29. Sep 2022 - 30. Sep 2022 • Prag, Tschechische Republik
Uventia Global
HPAPIs (highly potent active pharmaceutical ingredients) are potent molecules that may aid in the treatment of serious and life-threatening illnesses and disorders. At a certain time, due to their great potency, these compounds pose a risk to the production facility’s staff. On the one hand, special efforts must be taken to ensure operator safety, while on the other hand, great product quality is also necessary. Industry leaders, occupational toxicologists, and containment experts will share the most recent insights affecting the HPAPIs handling environment at our online meeting. Complex highly potent compound projects will be discussed, with a focus on safe and secure potent API processing, process development and scale-up, occupational health risks and toxicological assessment, advancements in isolators and facilities to reduce exposure risk, containment strategies and cross-contamination risk management, and more.
Tel.: [+420 732 640 977];     Email: info@uventia.com
HPAPI, API, Occupational Toxicology, Industrial Hygiene, Process Engineering, Cleaning Validation, Analytical Methods
Training — Chemical Development & Scale-Up in the Fine Chemical & Pharmaceutical Industries
17. Okt 2022 - 19. Okt 2022 • San Francisco, Vereinigte Staaten
iPharma — iPharma Expo 2022, USA
20. Okt 2022 - 21. Okt 2022 • Boston, Vereinigte Staaten
Infonet Events
iPharma Expo 2022, USA (International Pharmaceutical Business Expo 2022) scheduled during October 20-21, 2022, at Boston, U.S.A. This expo will showcase the latest trends and technologies in pharmaceuticals, drugs and formulations and will bring together eminent personalities from various sectors of pharma, non-pharma and healthcare industries.

Register for free at https://www.ipharmaexpo.com/visitor-registration/

iPharma Expo 2022 is expected to witness approx. 150 exhibitor’s and 1500- 2000 visitors footfall from pharma industry, management etc. bringing unique platform for the participating companies to display their products & services to the gamut of visitors, globally from pharma and healthcare industries.

Expo details- https://www.ipharmaexpo.com/exhibitor/

iPharma Expo, USA provides direct access to highly targeted senior pharma executives, buyers, procurement managers, contract manufacturers, hospital administration and many more Meet the business development managers who are looking for new supplies, building strategic partnerships or entering into new ventures.

Whether you are looking for sourcing new business or getting the latest market insight, as well as the wholesalers and hospital purchase personnel’s who seek to buy bulk products on concessional rates this is your one-stop shop global pharma platform.

Join us to expand your business presence in the leading pharmaceutical market USA.

Event Manager;     Tel.: [6193784851];     Email: info@ipharmaexpo.com
iPharma Expo USA, iPharma Expo 2022
EMBO Lecture Course — Microphysiological systems: Advances and applications in human-relevant research
31. Okt 2022 - 05. Nov 2022 • Hyderabad, Indien
European Molecular Biology Organization – EMBO
There has been an increasing awareness in the scientific community regarding the inability of animal models to often capture the complexities of human biology. In the last decade, there have been significant advances in the field of model systems that are based on human biology, including microphysiological systems (MPS). These systems aim to recapitulate the physiology and functions of a single human organ or a network of organs at a smaller scale, such as organoids or organs-on-chip. MPS have often been proposed as the next frontier of human-relevant research in drug discovery and testing. The lecture course will give an overview of the current research of how these model systems are being used to understand human disease and development. It will also cover design considerations, current challenges, setting standards and roadmap for broader adoption and use of these systems. In addition, the course would have networking sessions for early career researchers and students, along with discussions on collaborations, international grants, and entrepreneurship.
Einsendeschluss für Abstracts:
10. Aug 2022
Verwandte Fachgebiete:
Training — Molecule to Medicine
01. Nov 2022 - 03. Nov 2022 • Oxford, Großbritannien
Training — Understanding Polymorphism & Crystallisation Issues in the Pharmaceutical Industry
09. Nov 2022 - 11. Nov 2022 • Mailand, Italien
Pharma Conference 2022 — International Conference on Innovation and Advances in Pharmaceutical Sciences - Current Scenario and Future Perspectives
18. Nov 2022 - 19. Nov 2022 • Karnataka, Indien
Association of Pharmaceuticals Research
Adichunchanagiri University and Association of Pharmaceutical Research organizes the “International Conference on Innovation and Advances in Pharmaceutical Sciences - Current Scenario and Future Perspectives” on November 18th and 19th 2022.The Pharmaceutical sciences combine broad range of scientific disciplines that are critical to the discovery and development of new drugs and therapies.
Pharma Conference 2022, International Pharmaceutical Conference, Pharmaceutical Conference, Upcoming Pharmaceutical Conference, Pharma Conference, Pharma Conference in 2022, Upcoming Pharma Conference, International Pharma Conference, Pharmaceutical Conference, in Bangalore
Training — Quality by Design in Pharmaceutical Development
28. Nov 2022 - 02. Dez 2022 • Online Platform, Überall (Virtuelle Veranstaltung)
OMP 2023 — Optical Molecular Probes, Imaging and Drug Delivery
24. Apr 2023 - 27. Apr 2023 • Vancouver, BC, Kanada
Focuses on the convergence in these rapidly evolving areas, spanning from basic biology to clinical diagnostics and therapeutic applications. This multidisciplinary topical meeting will highlight recent advances in these rapidly evolving areas with a goal of stimulating novel strategies for molecular probe development, site-specific drug delivery, monitoring treatment response and clinical translation to improve diagnosis or treatment of diseases. Areas to be covered include, but are not limited to, novel molecular probe design, applications of smart molecular probes in basic and applied research, endogenous and exogenous optical molecular biomarkers, multimodal imaging, advances in instrumentation and algorithms for optical molecular imaging, molecular and functional imaging of normal and diseased tissue, image-guided drug delivery, drug screening and monitoring therapeutic response.
Verwandte Fachgebiete:

Conference-Service.com stellt der Öffentlichkeit ein Kalendarium wichtiger Konferenzen, Symposien und sonstiger Tagungen im wissenschaftlich-technischen Bereich zur Verfügung. Obwohl das Verzeichnis mit großer Sorgfalt zusammengestellt und ständig aktualisiert wird, weisen wir auf die Möglichkeit von Fehlern ausdrücklich hin. Bitte vergewissern Sie sich immer beim Veranstalter, bevor Sie über die Teilnahme oder Nichtteilnahme an einer Konferenz entscheiden.

Kein Tracking | Keine Pop-ups | Keine Animationen
Stand vom 24. Juni 2022